GI Alliance Research - Mansfield

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Fatty liver disease (MASLD/MASH)2 trials
• Crohn's disease1 trial
• Liver cirrhosis1 trial

Phase

• Phase 32 trials

Status

• Recruiting2 trials
• Active, not recruiting1 trial

Lead sponsor

• Boehringer Ingelheim2 trials
• Alimentiv Inc.1 trial

Running trials

• Recruiting

  LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

  NCT06632457· Phase 3· Boehringer Ingelheim· Source

  Contact: Boehringer Ingelheim

• Recruiting

  LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

  NCT06632444· Phase 3· Boehringer Ingelheim· Source

  Contact: Boehringer Ingelheim

• Active, not recruiting

  VOICE-Early Response to Vedolizumab and IL-23 Antagonists in Participants With Crohn's Disease: A Prospective Observational Study

  NCT06249555· Alimentiv Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Fatty liver disease (MASLD/MASH)2 recruiting
• Liver cirrhosis1 recruiting